Intermittent fasting and its impact on toxicities, symptoms and quality of life in patients on active cancer treatment.

ABSTRACT: Intermittent fasting is a dietary intervention that is increasingly being tested for positive outcomes in patients receiving cancer treatment. In this review, we examine the impact of intermittent fasting on symptoms, toxicities, and quality of life in patients undergoing cancer therapy and highlight unmet investigative areas to prompt future research. While current evidence is preliminary and conclusions mixed, some promising clinical studies suggest that intermittent fasting interventions may improve fatigue and reduce gastrointestinal toxicities in certain patients with cancer. Emerging clinical evidence also demonstrates that intermittent fasting may reduce off-target DNA damage, and induce favorable cellular-level immune remodeling. Furthermore, intermittent fasting has the potential

SUBMITTER: Li Sucholeiki R 

PROVIDER: S-EPMC11614448 | biostudies-literature | 2024 May

REPOSITORIES: biostudies-literature